Pharmacological control of head motion during cerebral blood flow imaging with CT or MRI

M Sesay1, A Jeannin, C T W Moonen

  • 1Department of Anesthesiology, Pellegrin university hospital, 33076 Bordeaux, France. musa.sesay@chu-bordeaux.fr

Insights

Pharmacological methods significantly reduce head motion during cerebral blood flow (CBF) imaging. General anesthesia and mild sedation protocols effectively minimize motion artifacts in pediatric and adult patients, improving scan quality.

Area of Science:

  • Medical Imaging
  • Neuroscience
  • Pharmacology

Background:

  • Uncontrolled head motion is a significant issue in CT/MRI cerebral blood flow (CBF) imaging, affecting 3-15% of scans.
  • Motion artifacts can compromise the diagnostic accuracy of CBF measurements.

Purpose of the Study:

  • To present a pharmacological approach to minimize head motion during CBF imaging.
  • To evaluate the efficacy and side effects of sedation and anesthesia protocols for motion reduction.

Main Methods:

  • Systematic use of general anesthesia (sevoflurane) for children under five and those with mental retardation.
  • Mild sedation with propofol, midazolam, or hydroxyzine for anxious, claustrophobic, or agitated adults.
  • Monitoring of cerebral blood flow (CBF) to assess the impact of pharmacological interventions.

Main Results:

  • The incidence of head motion was reduced to 0.06% with the proposed pharmacological protocol.
  • Sedation and anesthesia were associated with few side effects.
  • Mild effects on CBF were observed with mild sedation in adults.

Conclusions:

  • Pharmacological interventions, including general anesthesia and mild sedation, are highly effective in minimizing head motion during CBF imaging.
  • These methods offer a safe and efficient solution for improving image quality in challenging patient populations.
  • Availability of resuscitation equipment and a recovery room is crucial when administering sedation or general anesthesia.

Related Concept Videos

Brain Imaging01:14

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...